VolitionrxVNRX

13F holders, Q1 2024 (March 31)
24holders
$0.76avg. 13F price*

At the end of Q1 2024, 24 institutions reported holding Volitionrx Ltd. (VNRX) in their 13F filings. The largest holders were Lagoda Investment Management, L.P. ($3.8M), Vanguard Group Inc. ($482K) and Geode Capital Management, LLC ($467K).

Company
Volitionrx Ltd.
CUSIP
928661107
Latest filing quarter
Q1 2026

History

Number of 13F holders

010203040 Q1 2024: 24Q1 2024Q2 2024: 27Q2 2024Q3 2024: 22Q3 2024Q4 2024: 27Q4 2024Q1 2025: 25Q1 2025Q2 2025: 29Q2 2025Q3 2025: 33Q3 2025Q4 2025: 28Q4 2025Q1 2026: 31Q1 2026

Total Exit/New Position Q1 2024

InstitutionsTotal Value
New Positions2$38K
Exits6$49K

Ownership 24 holders

Lagoda Investment Management, L.P. 2.36% Add +36.1% 5,073,242 $3.8M
Vanguard Group Inc. 0.00% Add +1.0% 636,167 $482K
Geode Capital Management, LLC 0.00% Add +10.8% 617,366 $467K
BlackRock Inc. 0.00% Reduce -0.6% 573,760 $434K
Bridgeway Capital Management, LLC 0.00% Reduce -1.1% 174,180 $132K
Silverberg Bernstein Capital Management LLC 0.11% Reduce -1.6% 144,618 $109K
Morgan Stanley 0.00% Reduce -1.3% 134,000 $101K
State Street Corp. 0.00% No change 123,923 $94K
Northern Trust Corp. 0.00% Reduce -0.2% 89,389 $68K
Spectrum Asset Management, Inc. (NB/CA) 0.02% No change 55,596 $42K
Susquehanna International Group, LLP 0.00% New 50,076 $38K
Osaic Holdings, Inc. 0.00% Add +55.4% 30,020 $23K
UBS Group AG 0.00% Add +912.0% 28,458 $22K
Two Sigma Securities, LLC 0.00% Add +93.0% 22,682 $17K
Charles Schwab Investment Management Inc. 0.00% No change 15,384 $12K
Qube Research & Technologies Ltd 0.00% No change 6,344 $5K
Hartford Financial Management Inc. 0.00% No change 5,000 $4K
Tower Research Capital LLC (TRC) 0.00% Reduce -81.8% 2,526 $2K
Founders Capital Management 0.00% No change 2,000 $2K
Wells Fargo & Company 0.00% Add +2.4% 474 $359
BNP Paribas Financial Markets 0.00% No change 265 $201
Allworth Financial LP 0.00% No change 200 $152
Royal Bank of Canada 0.00% Reduce -91.1% 41 $0
Simplex Trading, LLC 0.00% New 475 $0

"% of holder's portfolio" is VNRX's weight in each manager's 13F, not the share of Volitionrx Ltd. the manager owns.